Advertisement
Australia markets closed
  • ALL ORDS

    8,012.10
    +1.60 (+0.02%)
     
  • AUD/USD

    0.6667
    -0.0006 (-0.09%)
     
  • ASX 200

    7,769.40
    -0.30 (-0.00%)
     
  • OIL

    81.68
    +0.11 (+0.13%)
     
  • GOLD

    2,353.30
    +6.40 (+0.27%)
     
  • Bitcoin AUD

    99,237.27
    +1,493.84 (+1.53%)
     
  • CMC Crypto 200

    1,376.81
    -5.85 (-0.42%)
     

Celldex Therapeutics to Present at Jefferies Healthcare Conference

Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.

HAMPTON, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 6th at 10:00 am ET. A webcast of the presentation will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com